Advanced search
Publication Cover
Current Medical Research and Opinion Volume 38, 2022 - Issue 3
Submit an article Journal homepage
3,218
Views
6
CrossRef citations to date
0
Altmetric
Oncology

Healthcare costs of colorectal cancer screening and events following colonoscopy among commercially insured average-risk adults in the United States

Deborah A. Fishera Division of Gastroenterology, Duke University, Durham, NC, USA
,
Nicole Princicb IBM Watson Health, Cambridge, MA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3127-4365
ORCID Icon,
Lesley-Ann Miller-Wilsonc Exact Sciences Corporation, Madison, WI, USA
,
Kathleen Wilsonb IBM Watson Health, Cambridge, MA, USA
&
Paul Limburgd Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
Pages 427-434 | Received 15 Jul 2021, Accepted 02 Dec 2021, Published online: 19 Dec 2021

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Derek Ebner, John Kisiel, Lianne Barnieh, Rishika Sharma, Nathaniel J. Smith, Chris Estes, Vahab Vahdat, A. Burak Ozbay, Paul Limburg & A. Mark Fendrick. (2023) The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population. Journal of Medical Economics 26:1, pages 1219-1226.
Read now

Articles from other publishers (5)

Holli A. Loomans-Kropp. (2024) The utility of liquid biopsy-based methylation biomarkers for colorectal cancer detection. Frontiers in Oncology 14.
Crossref
Bertrand Routy, Tanisha Jackson, Laura Mählmann, Christina K. Baumgartner, Martin Blaser, Allyson Byrd, Nathalie Corvaia, Kasey Couts, Diwakar Davar, Lisa Derosa, Howard C. Hang, Geke Hospers, Morten Isaksen, Guido Kroemer, Florent Malard, Kathy D. McCoy, Marlies Meisel, Sumanta Pal, Ze’ev Ronai, Eran Segal, Gregory D. Sepich-Poore, Fyza Shaikh, Randy F. Sweis, Giorgio Trinchieri, Marcel van den Brink, Rinse K. Weersma, Katrine Whiteson, Liping Zhao, Jennifer McQuade, Hassane Zarour & Laurence Zitvogel. (2024) Melanoma and microbiota: Current understanding and future directions. Cancer Cell 42:1, pages 16-34.
Crossref
Giuseppe Pierpaolo Merola, Ottone Baccaredda Boy, Isotta Fascina, Vincenzo Pecoraro, Andrea Falone, Andrea Patti, Gabriele Santarelli, David Colin Cicero, Andrea Ballerini & Valdo Ricca. (2023) Aberrant Salience Inventory: A meta‐analysis to investigate its psychometric properties and identify screening cutoff scores. Scandinavian Journal of Psychology 64:6, pages 734-745.
Crossref
A. Mark FendrickJohn B. KisielDurado BrooksVahab VahdatChris EstesDerek W. EbnerPaul Limburg. (2023) A Call to Action to Increase Uptake of Follow-Up Colonoscopy After Initial Positive Stool-Based Colorectal Cancer Screening. Population Health Management 26:6, pages 448-450.
Crossref
Arjun N. Patel & Jeffrey M. Sutton. (2022) No Money, Mo’ Problems: Financial Toxicity in the Realm of Cancer Screening. Journal of the National Comprehensive Cancer Network 20:9, pages 1069-1071.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.